Short Interest in Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) Expands By 100.0%

Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) was the target of a significant increase in short interest in October. As of October 15th, there was short interest totalling 5,800 shares, an increase of 100.0% from the September 30th total of 2,900 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Laboratorios Farmaceuticos Rovi Stock Performance

Shares of OTCMKTS:LABFF remained flat at C$90.61 during midday trading on Monday. Laboratorios Farmaceuticos Rovi has a 52 week low of C$90.61 and a 52 week high of C$90.61. The business has a 50 day simple moving average of C$90.61 and a 200 day simple moving average of C$88.75.

Laboratorios Farmaceuticos Rovi Company Profile

Laboratorios Farmaceuticos Rovi, SA engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas.